H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.9% of adults in Chesapeake have diagnosed diabetes — 0.9 points above the U.S. 12% figure. Census population 249,422. Virginia Medicare wound biologics: Palmetto GBA (JM). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Chesapeake clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Chesapeake storefront.
Extracellular Matrix (ECM) Therapy in Chesapeake, VA for clinics & physicians. ECM therapy products provid… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 12.9% of adults in Chesapeake have diagnosed diabetes — 0.9 points above the U.S. 12% figure. Obesity 40.1%; arthritis 26.5%. Those three PLACES crude rates (plus Census 249,422) are the local facts on this page. Everything else is the national extracellular matrix therapy catalog and JM paperwork.
National Extracellular Matrix (ECM) Therapy notes (how the product actually works)Virginia shares JM with NC, SC, WV. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 12.9% of adults in Chesapeake have diagnosed diabetes — 0.9 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 12.9% of adults in Chesapeake have diagnosed diabetes — 0.9 points above the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the extracellular matrix therapy account.
CDC PLACES (2023, crude prevalence) estimates 12.9% of adults — 0.9 points above the U.S. 12% figure. Obesity is 40.1%; arthritis is 26.5%. That is place-level BRFSS modeling, not a clinic census and not a Chesapeake trial.
No. They are B2B distribution pages for licensed providers. Patients in Chesapeake should speak with their clinician, not use a distributor URL as care instructions.
No. /kw pages explain distribution options. Protocol, privilege, and informed consent remain with the licensed Virginia clinician.
Yes. Tissue products come from FDA-registered banks with donor screening and lot traceability. Your receiving SOP should file IFU, lot, and indication with the chart. That packet is what JM reviewers and surveyors expect — not a brochure.
Bring specialty, monthly joint / regenerative volume, and whether you bill JM FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 12.9% diabetes and 26.5% arthritis for Chesapeake — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Chesapeake, VA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Chesapeake is JM geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Chesapeake — 0.9 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Virginia Part B wound biologics follow this contractor (siblings: NC, SC, WV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Chesapeake. Useful for joint-program math; still needs a diagnosis and privileging.
No Chesapeake storefront. Joe Bradley is an active practice owner. extracellular matrix therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.